Integromics has announced that the National Cancer Institute (NCI) and ESTools consortium have purchased a site-wide licence for Integromics' Realtime Statminer.
This RT-QPCR (real-time quantitative polymerase chain reaction) data analysis solution will be available to every researcher at the NCI and to ESTools consortium members.
Researchers will use this gene expression software technology to perform accelerated and validated bioinformatics analysis to gain new insights in the advancing cancer research and discovery field.
The solution will allow researchers to perform a standardised analysis of the functional gene expression data thereby offering a unified platform to look at gene expression.
'Realtime Statminer software v4.0 has helped us to streamline our QPCR data analyses, giving us greater confidence in the results,' said Prof Peter Andrews, co-ordinator of ESTools.
'In particular, it has given us a way to analyse data from Applied Biosystems Taqman array cards quickly and to provide robust methods for comparing the phenotype of different cell lines to specific standards,' he added.
Integromics has also announced the launch of the Realtime Statminer Free Edition.
The Free Edition contains features that will enable researchers to gain experience of Realtime Statminer without committing to purchasing the software.
